DOCS CFO exercises options at $4.12 and $2.21; now holds 369,793 Class A

Rhea-AI Filing Summary

Doximity, Inc. (DOCS) reported insider activity by its Chief Financial Officer. On 11/04/2025, the officer acquired 20,200 and 2,668 shares of Class A common stock, each labeled as a code C conversion from Class B following option exercises. The option exercises were at $4.12 and $2.21 per share, respectively.

Following these transactions, the officer beneficially owned 369,793 shares of Class A common stock, held directly. Footnotes state Class B shares are convertible into Class A on a one-for-one basis at the holder’s option, with automatic conversion upon certain events. The reported stock options carry expirations on 12/21/2030 and 09/28/2030, with vesting schedules as disclosed.

Insider Trade Summary

68,604 shares exercised/converted

Mixed 8 txns

Insider Bryson Anna

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	20,200	$0.00	--
Exercise	Class B Common Stock	20,200	$0.00	--
Conversion	Class B Common Stock	20,200	$0.00	--
Exercise	Stock Option (Right to Buy)	2,668	$0.00	--
Exercise	Class B Common Stock	2,668	$0.00	--
Conversion	Class B Common Stock	2,668	$0.00	--
Conversion	Class A Common Stock	20,200	$0.00	--
Conversion	Class A Common Stock	2,668	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 49,800 shares (Direct); Class B Common Stock — 20,200 shares (Direct); Class A Common Stock — 367,125 shares (Direct)

Footnotes (1)

1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. The stock option vests in 48 equal monthly installments after August 21, 2022, the fifth anniversary of the Reporting Person's hire date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on December 22, 2020. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. The stock option vests in 48 equal monthly installments after August 21, 2021, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on September 29, 2020.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bryson Anna

(Last) (First) (Middle)

DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/04/2025		C(1)		20,200	A	(1)	367,125	D
Class A Common Stock	11/04/2025		C(1)		2,668	A	(1)	369,793	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.12	11/04/2025		M			20,200	(2)	12/21/2030	Class B Common Stock(3)	20,200	$0	49,800	D
Class B Common Stock	(3)	11/04/2025		M		20,200		(3)	(3)	Class A Common Stock	20,200	$0	20,200	D
Class B Common Stock	(3)	11/04/2025		C(1)			20,200	(3)	(3)	Class A Common Stock	20,200	$0	0	D
Stock Option (Right to Buy)	$2.21	11/04/2025		M			2,668	(4)	09/28/2030	Class B Common Stock(3)	2,668	$0	100	D
Class B Common Stock	(3)	11/04/2025		M		2,668		(3)	(3)	Class A Common Stock	2,668	$0	2,668	D
Class B Common Stock	(3)	11/04/2025		C(1)			2,668	(3)	(3)	Class A Common Stock	2,668	$0	0	D

Explanation of Responses:

1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

2. The stock option vests in 48 equal monthly installments after August 21, 2022, the fifth anniversary of the Reporting Person's hire date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on December 22, 2020.

3. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

4. The stock option vests in 48 equal monthly installments after August 21, 2021, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on September 29, 2020.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ John Vaughan, Attorney-in-Fact	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Doximity (DOCS) disclose in this Form 4?

The CFO reported option exercises and conversions of Class B into Class A common stock on 11/04/2025.

How many Class A shares were acquired by the CFO of DOCS?

Two acquisitions: 20,200 shares and 2,668 shares, each recorded as conversions (code C).

What were the exercise prices for the options in the DOCS filing?

The options were exercised at $4.12 and $2.21 per share.

What is the CFO’s Class A beneficial ownership after the transactions?

Beneficial ownership was 369,793 Class A shares, held directly, after the reported transactions.

What is the conversion ratio between DOCS Class B and Class A shares?

Footnotes state a one-for-one conversion of Class B into Class A at the holder’s option, with certain automatic triggers.

When do the reported DOCS options expire?

The disclosed expirations are 12/21/2030 and 09/28/2030.